Sona Nanotech Inc C.SONA

Alternate Symbol(s): SNANF

Technology Scientific & Technical Instruments

Sona Nanotech Inc. is a nanotechnology life sciences company, which is engaged in developing targeted hyperthermia therapy. The Company has developed multiple methods for the manufacturing of various types of gold nanoparticles (GNR). It is engaged in research and development of its technology for use in multiplex diagnostic testing platforms and advanced biomedical applications. Its gold nanotechnologies are adapted for use in applications, as a safe and delivery system for multiple medical treatments, for the approval of various regulatory boards, including Health Canada and the Food and Drug administration (FDA). Its gold nanorod particles are manufactured without the use of cetyltrimethylammonium bromide (CTAB), eliminating the toxicity risks associated with the use of other gold nanorod technologies in medical applications. The Company is focused on the development of a pre-clinical nanomedical therapy for the treatment of cancer using its biocompatible GNR.

CSE:SONA - Post by User

Sona Nanotech Inc

Bullboard Posts

Comment by MikeyHon Sep 01, 2020 9:35am

156 Views

Post# 31485604

RE:100% specificity and selectivity in assymptomatics

Well, kinda. 3/3 is 100%, but if they had tested a handful more and missed the fourth then you're at 3/4 and 75%.

When you do the maths the symptomatic data isn't great frankly. The FDA position on this dataset will be interesting.

But, having said that picking up the 3 out of 40 positive asymptomatics is a good result. This really is a rollercoaster stock!

Bullboard Posts

Debt-free cannabis company set for next stage of growth